In Vitro and In Vivo Development of Horse Cloned Embryos Generated with iPSCs, Mesenchymal Stromal Cells and Fetal or Adult Fibroblasts as Nuclear Donors.
- Journal Article
Summary
This research study investigates ways to improve the efficiency of cloning horses, exploring the impact of different timings from cell fusion to activation and using various types of cells as nuclear donors, including induced pluripotent stem cells and mesenchymal stromal cells. The researchers identified an optimum timing interval for cell fusion and activation and determined that using certain types of nuclear donors can enhance the production rate of blastocysts.
Experiment Design
The scientists conducted a series of tests to optimize the process of equine cloning. They began by assessing the effects of various time intervals from cell fusion to activation on horse embryos created through cloning. The timings under examination were less than 1 hour, 1-2 hours, and 2-3 hours. The next step involved evaluating the impact of using diverse types of nuclear donor cells in two chained experiments. The cells used were:
- Induced pluripotent stem cells (iPSCs)
- Adult fibroblasts (AF)
- Ooplasts injected with pluripotency-inducing genes (OCT4, SOX2, MYC, and KLF4)
- Umbilical cord-derived mesenchymal stromal cells (UC-MSCs)
- Fetal fibroblasts (FF) derived from an unborn cloned foetus
Results of Time Interval Test
According to the study, the success rate of both blastocyst production and pregnancy was highest for the 2-3 hours group. There were no significant differences in the number of foals born per pregnancy when the 2-3 hours and the 1-2 hours timespan were employed.
Results of Different Cell Types Test
During the testing of varying cell types, it was observed that iPSCs did not generate any embryos at the blastocyst stage, and that the injection of oocytes with pluripotency-inducing genes did not necessarily lead to higher rates of blastocyst production or pregnancy. However, the researchers found that the use of UC-MSCs resulted in a significantly higher blastocyst production compared to using FF or AF.
Conclusions Drawn
Following these experiments, the study concluded that optimal blastocyst production can be achieved by employing a 2-3-hour gap between cell fusion and activation. Additionally, utilizing UC-MSCs as nuclear donors significantly improved the efficiency of blastocyst production. The study also suggested that the FF line might be used to improve the efficacy of an otherwise inefficient AF line. In total, out of 29 foals born, 24 healthy foals were obtained, indicating the potential application of these strategies in boosting the efficiency of equine cloning.
Cite This Article
Publication
Researcher Affiliations
- KHEIRON S.A Laboratory, Pilar, Buenos Aires, Argentina.
- Laboratory of Biology of Cell Development, LIAN-Unit associated with CONICET, FLENI, Belen de Escobar, Buenos Aires, Argentina.
- KHEIRON S.A Laboratory, Pilar, Buenos Aires, Argentina.
- Laboratory of Biology of Cell Development, LIAN-Unit associated with CONICET, FLENI, Belen de Escobar, Buenos Aires, Argentina.
- Laboratory of Biology of Cell Development, LIAN-Unit associated with CONICET, FLENI, Belen de Escobar, Buenos Aires, Argentina.
- Laboratory of Neruogenetic and Molecular Cytogentic, School of Sciences, National University of San Martin, CONICET, Buenos Aires, Argentina.
- The Roslin Institute and Royal School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.
- Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, United Kingdom.
- KHEIRON S.A Laboratory, Pilar, Buenos Aires, Argentina.
MeSH Terms
- Animals
- Blastocyst / cytology
- Cell Differentiation
- Cell Lineage
- Cell Nucleus / physiology
- Cells, Cultured
- Embryo Transfer
- Female
- Fetus / cytology
- Fibroblasts / cytology
- Horses
- Humans
- Induced Pluripotent Stem Cells / cytology
- Induced Pluripotent Stem Cells / metabolism
- Kruppel-Like Factor 4
- Mesenchymal Stem Cells / cytology
- Mesenchymal Stem Cells / metabolism
- Microinjections
- Nuclear Transfer Techniques
- Oocytes / cytology
- Plasmids / genetics
- Plasmids / metabolism
- Pregnancy
- Transcription Factors / genetics
- Transcription Factors / metabolism
- Umbilical Cord / cytology
Conflict of Interest Statement
References
Citations
This article has been cited 10 times.- Suvá M, Arnold VH, Wiedenmann EA, Jordan R, Galvagno E, Martínez M, Vichera GD. First sex modification case in equine cloning.. PLoS One 2023;18(1):e0279869.
- Yang XC, Wu XL, Li WH, Wu XJ, Shen QY, Li YX, Peng S, Hua JL. OCT6 inhibits differentiation of porcine-induced pluripotent stem cells through MAPK and PI3K signaling regulation.. Zool Res 2022 Nov 18;43(6):911-922.
- Yu B, van Tol HTA, Oei CHY, Stout TAE, Roelen BAJ. Lysophosphatidic Acid Accelerates Bovine In Vitro-Produced Blastocyst Formation through the Hippo/YAP Pathway.. Int J Mol Sci 2021 May 31;22(11).
- Lee AR, Park JH, Shim SH, Hong K, La H, Park KS, Lee DR. Genome stabilization by RAD51-stimulatory compound 1 enhances efficiency of somatic cell nuclear transfer-mediated reprogramming and full-term development of cloned mouse embryos.. Cell Prolif 2021 Jul;54(7):e13059.
- Hisey EA, Ross PJ, Meyers S. Genetic Manipulation of the Equine Oocyte and Embryo.. J Equine Vet Sci 2021 Apr;99:103394.
- Moro LN, Viale DL, Bastón JI, Arnold V, Suvá M, Wiedenmann E, Olguín M, Miriuka S, Vichera G. Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer.. Sci Rep 2020 Sep 24;10(1):15587.
- Pessôa LVF, Bressan FF, Freude KK. Induced pluripotent stem cells throughout the animal kingdom: Availability and applications.. World J Stem Cells 2019 Aug 26;11(8):491-505.
- Pessôa LVF, Pires PRL, Del Collado M, Pieri NCG, Recchia K, Souza AF, Perecin F, da Silveira JC, de Andrade AFC, Ambrosio CE, Bressan FF, Meirelles FV. Generation and miRNA Characterization of Equine Induced Pluripotent Stem Cells Derived from Fetal and Adult Multipotent Tissues.. Stem Cells Int 2019;2019:1393791.
- Moro LN, Amin G, Furmento V, Waisman A, Garate X, Neiman G, La Greca A, Santín Velazque NL, Luzzani C, Sevlever GE, Vichera G, Miriuka SG. MicroRNA characterization in equine induced pluripotent stem cells.. PLoS One 2018;13(12):e0207074.
- Olivera R, Moro LN, Jordan R, Pallarols N, Guglielminetti A, Luzzani C, Miriuka SG, Vichera G. Bone marrow mesenchymal stem cells as nuclear donors improve viability and health of cloned horses.. Stem Cells Cloning 2018;11:13-22.